Patriot Financial Group Insurance Agency, LLC Spero Therapeutics, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$704 Million
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$0.74 - $7.44 $888 - $8,928	-1,200 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$7.87 - $15.15 $23,216 - $44,692	-2,950 Reduced 71.08%	1,200 $10,000
Q4 2021 Jan 10, 2022	BUY	$13.09 - $18.77 $54,323 - $77,895	4,150 New	4,150 $66,000

Others Institutions Holding SPRO

# of Institutions

Shares Held

13.9M

Call Options Held

200

Put Options Held

200

Anson Funds Management LP Dallas, TX

3.75M
Shares

$3.23 Million
0.6% of portfolio
Vanguard Group Inc Valley Forge, PA

1.76M
Shares

$1.52 Million
0.0% of portfolio
Atlas Venture Associates Ix, LLC Boston, MA

1.35M
Shares

$1.16 Million
14.54% of portfolio
Acadian Asset Management LLC Boston, MA

1.07M
Shares

$921,799
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

975K
Shares

$838,201
0.0% of portfolio

View Full List

About Spero Therapeutics, Inc.

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $30.2M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

More about SPRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account